Armored human CAR T reg cells with PD1 promoter-driven IL-10 have enhanced suppressive function
Science Advances · 13.06.2025 · 11 (24)
DOI: 10.1126/sciadv.adx7845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 13.06.2025. Verfasst von Dominic A Boardman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Interleukin-10, T-Lymphocytes, Regulatory, Programmed Cell Death 1 Receptor, Promoter Regions, Genetic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Regulatory T cell (T reg cell) therapy has been transformed through the use of chimeric antigen receptors (CARs). We previously found that human T reg cells minimally produce IL-10 and have a limited capacity to control innate immunity compared to type 1 regulatory T cells (T r 1 cells). To create “hybrid” CAR T reg cells with T r 1 cell-like properties, we examined whether the PDCD1 locus could be exploited to endow T reg cells with CAR-regulated IL-10 expression. CRISPR-mediated PD1 deletion increased CAR T reg cell activation, and knock-in of IL10 under control of the PD1 promoter resulted in CAR-induced IL-10 secretion. IL10 knock-in improved CAR T reg cell function, as determined by increased suppression of dendritic cells and alloantigen- and islet autoantigen–specific T cells. In vivo, IL10 knock-in CAR T reg cells were stable, safe, and suppressed dendritic cells and xenogeneic graft-versus-host disease. CRISPR-mediated engineering to simultaneously remove an inhibitory signal and enhance a suppressive mechanism is a previously unexplored approach to improve CAR T reg cell potency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, The University of British Columbia, Vancouver, BC, Canada.
- BC Children's Hospital Research Institute, Vancouver, BC, Canada.
- Department of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada.
- Department of Pathology, Stanford University, Stanford, CA, USA.
- School of Biomedical Engineering, The University of British Columbia, Vancouver, BC, Canada.
ORCID-Profile: Dominic A Boardman, Sonya Mangat, Vivian C W Fung, Manjurul Haque, Majid Mojibian, Torin Halvorson, Karoliina Tuomela, Christine M Wardell, Avery J Lam, Megan K Levings
Zitieren
APA
Boardman, D. A., Mangat, S., Gillies, J. K., Leon, L., Fung, V. C. W., Haque, M., Mojibian, M., Halvorson, T., Huang, Q., Tuomela, K., Wardell, C. M., Brown, A., Lam, A. J., & Levings, M. K. (2025). Armored human CAR T reg cells with PD1 promoter-driven IL-10 have enhanced suppressive function. Science Advances, 11(24). https://doi.org/10.1126/sciadv.adx7845
Vancouver
Boardman DA, Mangat S, Gillies JK, Leon L, Fung VCW, Haque M, et al. Armored human CAR T reg cells with PD1 promoter-driven IL-10 have enhanced suppressive function. Science Advances. 2025;11(24). doi:10.1126/sciadv.adx7845
BibTeX
@article{Boardman2025,
author = {Boardman, Dominic A and Mangat, Sonya and Gillies, Jana K and Leon, Lorna and Fung, Vivian C W and Haque, Manjurul and Mojibian, Majid and Halvorson, Torin and Huang, Qing and Tuomela, Karoliina and Wardell, Christine M and Brown, Andrew and Lam, Avery J and Levings, Megan K},
title = {Armored human CAR T reg cells with PD1 promoter-driven IL-10 have enhanced suppressive function},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {24},
doi = {10.1126/sciadv.adx7845}
}
EUVIMED